Normotensive and hypertensive Immunoglobulin a nephropathy with ischemic renal injury: clinicopathological characteristics and prognosis
This study aimed to investigate the clinicopathological characteristics and prognosis of normotensive and hypertensive IgAN patients with ischemic renal injury. A total of 344 cases of IgAN with ischemic renal injury were included in the study, including 99 normotensive IgAN patients (28.8%) and 245...
Gespeichert in:
| Veröffentlicht in: | Renal failure 2021-01, Vol.43 (1), p.1454-1462 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1462 |
|---|---|
| container_issue | 1 |
| container_start_page | 1454 |
| container_title | Renal failure |
| container_volume | 43 |
| creator | Wang, Yongli Wang, Xutong Yu, Dan Xie, Minhua Ren, Jingjing Zhu, Yuze Guo, Haonan Quan, Songxia Zhang, Junjun |
| description | This study aimed to investigate the clinicopathological characteristics and prognosis of normotensive and hypertensive IgAN patients with ischemic renal injury.
A total of 344 cases of IgAN with ischemic renal injury were included in the study, including 99 normotensive IgAN patients (28.8%) and 245 hypertensive IgAN patients (71.2%). In addition, 467 IgAN patients without ischemic renal injury were included as controls, including 205 normotensive patients and 262 hypertensive patients. Clinicopathological and prognostic data were collected and analyzed.
Compared with patients without ischemic renal injury, IgAN patients with ischemic renal injury displayed a higher proportion of hypertention, a higher proportion of ischemic glomerulosclerosis, tubular atrophy/interstitial fibrosis and vascular lesions (all p |
| doi_str_mv | 10.1080/0886022X.2021.1994996 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8555525</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_610ba952f8ef4a91a7b4ffc76b1d44f4</doaj_id><sourcerecordid>2586998631</sourcerecordid><originalsourceid>FETCH-LOGICAL-c562t-d53e743793252f0bda39d451d25efb013d2fb716389960b05d3b19511030a7253</originalsourceid><addsrcrecordid>eNp9ksmO1DAQhiMEYpqBRwBF4sKlG69JzAENGrG0NIILSNwsx0vilmMHO5lR3oDHxr2NGA74Yqnqq78W_UXxEoINBA14C5qmAgj93CCA4AYyRhirHhUrSBFdV4Cwx8Vqz6z30EXxLKUdAJA2NXpaXGBSA9IwuCp-fw1xCJP2yd7qUnhV9suo4zmwHYbZh86FdnbWl6L0euxjGMXUL-WdnfrSJtnrwcoyai9caf1ujsu7UmbcygMYXOiszDnZiyjkpKNNk5Xp0G2MofMh2fS8eGKES_rF6b8sfnz6-P36y_rm2-ft9YebtaQVmtaKYl0TXDOMKDKgVQIzRShUiGrTAogVMm0NK9zkc4AWUIVbyCiEAANRI4ovi-1RVwWx42O0g4gLD8LyQyDEjouYx3OaVxC0guU2jTZEMCjqlhgj66qFihBDstb7o9Y4t4NWUvspCvdA9GHG25534ZY3NL_DMG9OAjH8mnWa-JDvqZ0TXoc5cUSbirGmwjCjr_9Bd2GO-eSZqhEErM4GyBQ9UjKGlKI298NAwPe-4Wff8L1v-Mk3ue7V35vcV52NkoGrI2C9yY4RdyE6xSexuBBNFF7axPH_e_wB_PrWWQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2721097499</pqid></control><display><type>article</type><title>Normotensive and hypertensive Immunoglobulin a nephropathy with ischemic renal injury: clinicopathological characteristics and prognosis</title><source>Taylor & Francis Open Access</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Wang, Yongli ; Wang, Xutong ; Yu, Dan ; Xie, Minhua ; Ren, Jingjing ; Zhu, Yuze ; Guo, Haonan ; Quan, Songxia ; Zhang, Junjun</creator><creatorcontrib>Wang, Yongli ; Wang, Xutong ; Yu, Dan ; Xie, Minhua ; Ren, Jingjing ; Zhu, Yuze ; Guo, Haonan ; Quan, Songxia ; Zhang, Junjun</creatorcontrib><description>This study aimed to investigate the clinicopathological characteristics and prognosis of normotensive and hypertensive IgAN patients with ischemic renal injury.
A total of 344 cases of IgAN with ischemic renal injury were included in the study, including 99 normotensive IgAN patients (28.8%) and 245 hypertensive IgAN patients (71.2%). In addition, 467 IgAN patients without ischemic renal injury were included as controls, including 205 normotensive patients and 262 hypertensive patients. Clinicopathological and prognostic data were collected and analyzed.
Compared with patients without ischemic renal injury, IgAN patients with ischemic renal injury displayed a higher proportion of hypertention, a higher proportion of ischemic glomerulosclerosis, tubular atrophy/interstitial fibrosis and vascular lesions (all p < .05). There was no significant difference in cumulative survival between the normotensive IgAN patients groups (Log-rank χ
2
= 0.479; p = .489). Furthermore, ischemic renal injury was not a risk factor for end-point events in normotensive IgAN patients (HR = 1.103; 95% CI: 0.279-4.365; p = .889). There was lower cumulative survival in hypertensive IgAN patients with ischemic renal injury (Log-rank χ
2
= 11.352, p = .001). Moreover, ischemic renal injury was a risk factor for end-point events in hypertensive IgAN patients (HR = 1.889; 95% CI: 1.124-3.178; p = .016).
Ischemic renal injury can occur in normotensive IgAN patients. Although the pathological changes may not affect the long-term prognosis of normotensive IgAN patients, the prognosis for hypertensive IgAN patients remains poor. Therefore, increased attention should be paid to the clinical management of ischemic lesions in hypertensive IgAN patients.</description><identifier>ISSN: 0886-022X</identifier><identifier>EISSN: 1525-6049</identifier><identifier>DOI: 10.1080/0886022X.2021.1994996</identifier><identifier>PMID: 34704891</identifier><language>eng</language><publisher>England: Taylor & Francis</publisher><subject>Acute Kidney Injury - etiology ; Acute Kidney Injury - pathology ; Acute Kidney Injury - physiopathology ; Adult ; Atrophy ; Blood Pressure ; Clinical Study ; Female ; Fibrosis ; Glomerular Filtration Rate ; Glomerulonephritis, IGA - complications ; Glomerulonephritis, IGA - physiopathology ; Humans ; Hypertension ; Hypertension - etiology ; Hypertension - physiopathology ; IgA nephropathy ; Immunoglobulin A ; Ischemia ; ischemic renal injury ; Kidneys ; Male ; Medical prognosis ; Nephropathy ; Patients ; Prognosis ; Proportional Hazards Models ; renal biopsy ; Retrospective Studies ; Risk Factors ; Survival</subject><ispartof>Renal failure, 2021-01, Vol.43 (1), p.1454-1462</ispartof><rights>2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021</rights><rights>2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c562t-d53e743793252f0bda39d451d25efb013d2fb716389960b05d3b19511030a7253</citedby><cites>FETCH-LOGICAL-c562t-d53e743793252f0bda39d451d25efb013d2fb716389960b05d3b19511030a7253</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555525/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555525/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,27502,27924,27925,53791,53793,59143,59144</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34704891$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Yongli</creatorcontrib><creatorcontrib>Wang, Xutong</creatorcontrib><creatorcontrib>Yu, Dan</creatorcontrib><creatorcontrib>Xie, Minhua</creatorcontrib><creatorcontrib>Ren, Jingjing</creatorcontrib><creatorcontrib>Zhu, Yuze</creatorcontrib><creatorcontrib>Guo, Haonan</creatorcontrib><creatorcontrib>Quan, Songxia</creatorcontrib><creatorcontrib>Zhang, Junjun</creatorcontrib><title>Normotensive and hypertensive Immunoglobulin a nephropathy with ischemic renal injury: clinicopathological characteristics and prognosis</title><title>Renal failure</title><addtitle>Ren Fail</addtitle><description>This study aimed to investigate the clinicopathological characteristics and prognosis of normotensive and hypertensive IgAN patients with ischemic renal injury.
A total of 344 cases of IgAN with ischemic renal injury were included in the study, including 99 normotensive IgAN patients (28.8%) and 245 hypertensive IgAN patients (71.2%). In addition, 467 IgAN patients without ischemic renal injury were included as controls, including 205 normotensive patients and 262 hypertensive patients. Clinicopathological and prognostic data were collected and analyzed.
Compared with patients without ischemic renal injury, IgAN patients with ischemic renal injury displayed a higher proportion of hypertention, a higher proportion of ischemic glomerulosclerosis, tubular atrophy/interstitial fibrosis and vascular lesions (all p < .05). There was no significant difference in cumulative survival between the normotensive IgAN patients groups (Log-rank χ
2
= 0.479; p = .489). Furthermore, ischemic renal injury was not a risk factor for end-point events in normotensive IgAN patients (HR = 1.103; 95% CI: 0.279-4.365; p = .889). There was lower cumulative survival in hypertensive IgAN patients with ischemic renal injury (Log-rank χ
2
= 11.352, p = .001). Moreover, ischemic renal injury was a risk factor for end-point events in hypertensive IgAN patients (HR = 1.889; 95% CI: 1.124-3.178; p = .016).
Ischemic renal injury can occur in normotensive IgAN patients. Although the pathological changes may not affect the long-term prognosis of normotensive IgAN patients, the prognosis for hypertensive IgAN patients remains poor. Therefore, increased attention should be paid to the clinical management of ischemic lesions in hypertensive IgAN patients.</description><subject>Acute Kidney Injury - etiology</subject><subject>Acute Kidney Injury - pathology</subject><subject>Acute Kidney Injury - physiopathology</subject><subject>Adult</subject><subject>Atrophy</subject><subject>Blood Pressure</subject><subject>Clinical Study</subject><subject>Female</subject><subject>Fibrosis</subject><subject>Glomerular Filtration Rate</subject><subject>Glomerulonephritis, IGA - complications</subject><subject>Glomerulonephritis, IGA - physiopathology</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - etiology</subject><subject>Hypertension - physiopathology</subject><subject>IgA nephropathy</subject><subject>Immunoglobulin A</subject><subject>Ischemia</subject><subject>ischemic renal injury</subject><subject>Kidneys</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Nephropathy</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Proportional Hazards Models</subject><subject>renal biopsy</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Survival</subject><issn>0886-022X</issn><issn>1525-6049</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><sourceid>DOA</sourceid><recordid>eNp9ksmO1DAQhiMEYpqBRwBF4sKlG69JzAENGrG0NIILSNwsx0vilmMHO5lR3oDHxr2NGA74Yqnqq78W_UXxEoINBA14C5qmAgj93CCA4AYyRhirHhUrSBFdV4Cwx8Vqz6z30EXxLKUdAJA2NXpaXGBSA9IwuCp-fw1xCJP2yd7qUnhV9suo4zmwHYbZh86FdnbWl6L0euxjGMXUL-WdnfrSJtnrwcoyai9caf1ujsu7UmbcygMYXOiszDnZiyjkpKNNk5Xp0G2MofMh2fS8eGKES_rF6b8sfnz6-P36y_rm2-ft9YebtaQVmtaKYl0TXDOMKDKgVQIzRShUiGrTAogVMm0NK9zkc4AWUIVbyCiEAANRI4ovi-1RVwWx42O0g4gLD8LyQyDEjouYx3OaVxC0guU2jTZEMCjqlhgj66qFihBDstb7o9Y4t4NWUvspCvdA9GHG25534ZY3NL_DMG9OAjH8mnWa-JDvqZ0TXoc5cUSbirGmwjCjr_9Bd2GO-eSZqhEErM4GyBQ9UjKGlKI298NAwPe-4Wff8L1v-Mk3ue7V35vcV52NkoGrI2C9yY4RdyE6xSexuBBNFF7axPH_e_wB_PrWWQ</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Wang, Yongli</creator><creator>Wang, Xutong</creator><creator>Yu, Dan</creator><creator>Xie, Minhua</creator><creator>Ren, Jingjing</creator><creator>Zhu, Yuze</creator><creator>Guo, Haonan</creator><creator>Quan, Songxia</creator><creator>Zhang, Junjun</creator><general>Taylor & Francis</general><general>Taylor & Francis Ltd</general><general>Taylor & Francis Group</general><scope>0YH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7XB</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20210101</creationdate><title>Normotensive and hypertensive Immunoglobulin a nephropathy with ischemic renal injury: clinicopathological characteristics and prognosis</title><author>Wang, Yongli ; Wang, Xutong ; Yu, Dan ; Xie, Minhua ; Ren, Jingjing ; Zhu, Yuze ; Guo, Haonan ; Quan, Songxia ; Zhang, Junjun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c562t-d53e743793252f0bda39d451d25efb013d2fb716389960b05d3b19511030a7253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acute Kidney Injury - etiology</topic><topic>Acute Kidney Injury - pathology</topic><topic>Acute Kidney Injury - physiopathology</topic><topic>Adult</topic><topic>Atrophy</topic><topic>Blood Pressure</topic><topic>Clinical Study</topic><topic>Female</topic><topic>Fibrosis</topic><topic>Glomerular Filtration Rate</topic><topic>Glomerulonephritis, IGA - complications</topic><topic>Glomerulonephritis, IGA - physiopathology</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - etiology</topic><topic>Hypertension - physiopathology</topic><topic>IgA nephropathy</topic><topic>Immunoglobulin A</topic><topic>Ischemia</topic><topic>ischemic renal injury</topic><topic>Kidneys</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Nephropathy</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Proportional Hazards Models</topic><topic>renal biopsy</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Survival</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Yongli</creatorcontrib><creatorcontrib>Wang, Xutong</creatorcontrib><creatorcontrib>Yu, Dan</creatorcontrib><creatorcontrib>Xie, Minhua</creatorcontrib><creatorcontrib>Ren, Jingjing</creatorcontrib><creatorcontrib>Zhu, Yuze</creatorcontrib><creatorcontrib>Guo, Haonan</creatorcontrib><creatorcontrib>Quan, Songxia</creatorcontrib><creatorcontrib>Zhang, Junjun</creatorcontrib><collection>Taylor & Francis Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Renal failure</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Yongli</au><au>Wang, Xutong</au><au>Yu, Dan</au><au>Xie, Minhua</au><au>Ren, Jingjing</au><au>Zhu, Yuze</au><au>Guo, Haonan</au><au>Quan, Songxia</au><au>Zhang, Junjun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Normotensive and hypertensive Immunoglobulin a nephropathy with ischemic renal injury: clinicopathological characteristics and prognosis</atitle><jtitle>Renal failure</jtitle><addtitle>Ren Fail</addtitle><date>2021-01-01</date><risdate>2021</risdate><volume>43</volume><issue>1</issue><spage>1454</spage><epage>1462</epage><pages>1454-1462</pages><issn>0886-022X</issn><eissn>1525-6049</eissn><abstract>This study aimed to investigate the clinicopathological characteristics and prognosis of normotensive and hypertensive IgAN patients with ischemic renal injury.
A total of 344 cases of IgAN with ischemic renal injury were included in the study, including 99 normotensive IgAN patients (28.8%) and 245 hypertensive IgAN patients (71.2%). In addition, 467 IgAN patients without ischemic renal injury were included as controls, including 205 normotensive patients and 262 hypertensive patients. Clinicopathological and prognostic data were collected and analyzed.
Compared with patients without ischemic renal injury, IgAN patients with ischemic renal injury displayed a higher proportion of hypertention, a higher proportion of ischemic glomerulosclerosis, tubular atrophy/interstitial fibrosis and vascular lesions (all p < .05). There was no significant difference in cumulative survival between the normotensive IgAN patients groups (Log-rank χ
2
= 0.479; p = .489). Furthermore, ischemic renal injury was not a risk factor for end-point events in normotensive IgAN patients (HR = 1.103; 95% CI: 0.279-4.365; p = .889). There was lower cumulative survival in hypertensive IgAN patients with ischemic renal injury (Log-rank χ
2
= 11.352, p = .001). Moreover, ischemic renal injury was a risk factor for end-point events in hypertensive IgAN patients (HR = 1.889; 95% CI: 1.124-3.178; p = .016).
Ischemic renal injury can occur in normotensive IgAN patients. Although the pathological changes may not affect the long-term prognosis of normotensive IgAN patients, the prognosis for hypertensive IgAN patients remains poor. Therefore, increased attention should be paid to the clinical management of ischemic lesions in hypertensive IgAN patients.</abstract><cop>England</cop><pub>Taylor & Francis</pub><pmid>34704891</pmid><doi>10.1080/0886022X.2021.1994996</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0886-022X |
| ispartof | Renal failure, 2021-01, Vol.43 (1), p.1454-1462 |
| issn | 0886-022X 1525-6049 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8555525 |
| source | Taylor & Francis Open Access; MEDLINE; DOAJ Directory of Open Access Journals; PubMed Central; Alma/SFX Local Collection |
| subjects | Acute Kidney Injury - etiology Acute Kidney Injury - pathology Acute Kidney Injury - physiopathology Adult Atrophy Blood Pressure Clinical Study Female Fibrosis Glomerular Filtration Rate Glomerulonephritis, IGA - complications Glomerulonephritis, IGA - physiopathology Humans Hypertension Hypertension - etiology Hypertension - physiopathology IgA nephropathy Immunoglobulin A Ischemia ischemic renal injury Kidneys Male Medical prognosis Nephropathy Patients Prognosis Proportional Hazards Models renal biopsy Retrospective Studies Risk Factors Survival |
| title | Normotensive and hypertensive Immunoglobulin a nephropathy with ischemic renal injury: clinicopathological characteristics and prognosis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T23%3A24%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Normotensive%20and%20hypertensive%20Immunoglobulin%20a%20nephropathy%20with%20ischemic%20renal%20injury:%20clinicopathological%20characteristics%20and%20prognosis&rft.jtitle=Renal%20failure&rft.au=Wang,%20Yongli&rft.date=2021-01-01&rft.volume=43&rft.issue=1&rft.spage=1454&rft.epage=1462&rft.pages=1454-1462&rft.issn=0886-022X&rft.eissn=1525-6049&rft_id=info:doi/10.1080/0886022X.2021.1994996&rft_dat=%3Cproquest_pubme%3E2586998631%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2721097499&rft_id=info:pmid/34704891&rft_doaj_id=oai_doaj_org_article_610ba952f8ef4a91a7b4ffc76b1d44f4&rfr_iscdi=true |